Top Markets
Coin of the day
20/20 Biolabs Inc. 20/20 Biolabs Inc.

20/20 Biolabs Inc.

AIDX
株式のランク #33866
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
株価
$0.5475
最終同期: 2026-08-14
時価総額
$6.71M
変化(1日)
5.57%
変化(1年)
-
US
取引 20/20 Biolabs Inc. (AIDX)

カテゴリー

20/20 Biolabs Inc.(AIDX)の配当利回りの履歴
20/20 Biolabs Inc.(銘柄コード: AIDX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
20/20 Biolabs Inc.(AIDX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)